Moderna Forecast -8.2%: Plunge as $39 Target Alarms Bulls
Can Moderna’s pipeline story outweigh a brutal valuation reset, or is the latest sell-off warning investors not to chase the rally? Maik Kemper Editor in Chief Because it…
Can Moderna’s pipeline story outweigh a brutal valuation reset, or is the latest sell-off warning investors not to chase the rally? Maik Kemper Editor in Chief Because it…